Akèy › Sarkom tisi mou › New York › New York City
Etid klinik pou Sarkom tisi mou nan New York City, NY
19 etid pou Sarkom tisi mou ap chèche patisipan nan sit nan ak bò kote New York City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center, New York
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A Study of CRD3874-SI in People With Solid Tumors
Ap rekriteFaz 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Cancer Center, New York
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Ap rekriteFaz 1/2
- New York University Langone Health, New York
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Cancer Center, New York
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Ap rekriteFaz 1
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
Ap rekriteFaz 1
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Ap rekrite
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Actinium Therapy for Late-stage Aggressive Sarcomas
Ap rekriteFaz 1
- Memorial Sloane Kettering Cancer Center, New York
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
Ap rekriteEtid obsèvasyon
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
Ap rekriteFaz 1
- Zai Lab Site 02002, New York
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
Ap rekrite
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center, New York
A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Centre, New York
Phase II Trial of Lung Chemoemobolization
Ap rekriteFaz 2
- Memorial Sloan Kettering Cancer Center, New York
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Cancer Center, New York
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Ap rekriteFaz 1/2
- Memorial Sloan-Kettering Cancer Center, New York
Etid Sarkom tisi mou nan lòt vil
- Houston, TX32 etid
- Boston, MA18 etid
- St. Louis, MO14 etid
- Los Angeles, CA13 etid
- Columbus, OH13 etid
- Washington, DC12 etid
- Memphis, TN11 etid
- Philadelphia, PA10 etid
- Nashville, TN9 etid
- Rochester, MN9 etid
- Queens, NY9 etid
- Aurora, CO9 etid
Lòt etid nan New York City
- Kansè nan tete136 etid
- Kansè Poumon ki pa ti selil121 etid
- Kansè (tout kalite)109 etid
- Kansè pwostat103 etid
- Kansè Metastatik93 etid
- Kansè kolorektal78 etid
- Kansè ovè69 etid
- Kansè poumon60 etid
- Myelom Miltip60 etid
- Kansè pankreyas60 etid
- Kansè Endomèt52 etid
- Leksemi mieloïd egi51 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.